Zurück

Wählen Sie Ihre Region

Corporate

Vereinbaren Sie ein Beratungsgespräch über Stammzellen

Mehr erfahren

Unsere
Transplantationen

Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:

Obraz
Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:
Nr. Quelle Quellentyp Diagnose Medizinbereich Anwendungsjahr Therapie Land Alter des Empfängers
3801 Apheresis Autologous Germ Cell Tumor Hematology 2021 Standard Therapy Germany 28
3802 Apheresis Allogeneic Hemophagocytic Lymphohistiocytosis (Hlh) Hematology 2021 Standard Therapy Poland 23
3803 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 41
3804 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 40
3805 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 27
3806 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 19
3807 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 26
3808 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 32
3809 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2021 Standard Therapy Germany 21
3810 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2021 Standard Therapy Germany 37
3811 Apheresis Autologous Hodgkin Lymphoma Hematology 2021 Standard Therapy Germany 30
3812 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2021 Standard Therapy Germany 47
3813 Apheresis Autologous Hodgkin Lymphoma Hematology 2021 Standard Therapy Germany 36
3814 Apheresis Autologous Hodgkin Lymphoma Hematology 2021 Standard Therapy Germany 30
3815 Apheresis Allogeneic Hurler Syndrome Hematology 2021 Standard Therapy Poland 2
3816 Apheresis Allogeneic Immunodeficiency Hematology 2021 Standard Therapy Poland 12
3817 Apheresis Allogeneic Leukemia Hematology 2021 Standard Therapy Poland 63
3818 Apheresis Allogeneic Lymphoma Hematology 2021 Standard Therapy Poland 58
3819 Apheresis Autologous Mantle Cell Lymphoma Hematology 2021 Standard Therapy Germany 66
3820 Apheresis Autologous Mantle Cell Lymphoma Hematology 2021 Standard Therapy Germany 57
3821 Apheresis Autologous Mantle Cell Lymphoma Hematology 2021 Standard Therapy Germany 66
3822 Apheresis Autologous Mantle Cell Lymphoma Hematology 2021 Standard Therapy Germany 57
3823 Apheresis Autologous Mantle Cell Lymphoma Hematology 2021 Standard Therapy Germany 63
3824 Apheresis Autologous Mantle Cell Lymphoma Hematology 2021 Standard Therapy Germany 56
3825 Apheresis Autologous Mantle Cell Lymphoma Hematology 2021 Standard Therapy Germany 65
3826 Apheresis Allogeneic Metachromatic Leukodystrophy Hematology 2021 Standard Therapy Poland 60
3827 Apheresis Autologous Morbus Hodgkin Hematology 2021 Standard Therapy Germany 36
3828 Apheresis Autologous Morbus Hodgkin Hematology 2021 Standard Therapy Germany 50
3829 Apheresis Autologous Morbus Hodgkin Hematology 2021 Standard Therapy Germany 21
3830 Apheresis Allogeneic Mucopolysaccharidosis Hematology 2021 Standard Therapy Poland 2
3831 Apheresis Allogeneic Multiple Myeloma Hematology 2021 Standard Therapy Poland 44
3832 Apheresis Allogeneic Multiple Myeloma Hematology 2021 Standard Therapy Poland 60
3833 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 70
3834 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 71
3835 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 53
3836 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 51
3837 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 61
3838 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 65
3839 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 62
3840 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 57
3841 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 66
3842 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 50
3843 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 65
3844 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 50
3845 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 47
3846 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 43
3847 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 66
3848 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 56
3849 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 65
3850 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 51
3851 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 61
3852 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 62
3853 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 68
3854 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 70
3855 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 70
3856 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 38
3857 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 61
3858 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 63
3859 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 71
3860 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 52
3861 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 63
3862 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 57
3863 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 68
3864 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 61
3865 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 58
3866 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 57
3867 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 60
3868 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 58
3869 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 67
3870 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 62
3871 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 42
3872 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 61
3873 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 67
3874 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 57
3875 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 68
3876 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 68
3877 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 41
3878 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 60
3879 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 8
3880 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 61
3881 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 62
3882 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 68
3883 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 65
3884 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 56
3885 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 62
3886 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 57
3887 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 47
3888 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 65
3889 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 29
3890 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 66
3891 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 70
3892 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 70
3893 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 59
3894 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 50
3895 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 59
3896 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 28
3897 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 68
3898 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 65
3899 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 54
3900 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 66